bioRxivImmunology
Early data on the performance of a combined SARS-CoV-2 spike-nucleocapsid antibody lateral flow device compared to a nucleocapsid-only device
Abstract
The authors have withdrawn their manuscript whilst they perform additional experiments to test some of their conclusions further. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Nanoparticle-Supported, Rapid, Digital Quantification of Neutralizing Antibodies Against SARS-CoV-2 Variants
Seyedsina Mirjalili, Md Ashif Ikbal, … Chao Wang·Biosensors and BioelectronicsPeer-reviewed·Nov 6, 2024
- Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type.
P. R. Lephart, M. A. Bachman, … D. W. Newton·bioRxiv·Jun 4, 2020
- A Rapid Bead-Based Assay For Screening Of SARS-CoV-2 Neutralising Antibodies
Santhik Subhasingh Lupitha, Pramod Darvin, … Thankayyan Retnabai Santhoshkumar·Antibody TherapeuticsPeer-reviewed·Mar 17, 2022
- Rigid monoclonal antibodies improve detection of SARS-CoV-2 nucleocapsid protein
C. D. Hodge, D. J. Rosenberg, … M. Hammel·bioRxiv·Jan 13, 2021
- A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
A. E. Muruato, C. R. Fontes-Garfias, … P.-Y. Shi·bioRxiv·May 21, 2020
- Surface detection of SARS-CoV-2 by lateral flow LAMP
Isabelle Dahl Acker, Mark Joseph Ware, John R. Bracht·bioRxiv·Apr 4, 2022